Author Question: The cornerstone of U.S. environmental regulation of exports is the concept of: A) receiving the ... (Read 77 times)

RODY.ELKHALIL

  • Hero Member
  • *****
  • Posts: 591
The cornerstone of U.S. environmental regulation of exports is the concept of:
 A) receiving the prior informed consent of the foreign countries to which the exports are going.
 B) U.S. firms may not export any hazardous materials that they could not sell in the United States.
 C) advance permission to export from the Environmental Protection Agency.
 D) receiving advance permission from the United Nations before exporting hazardous or toxic materials.

Question 2

Maintaining confidentiality is an ethical issue for both employees and company management.
  Indicate whether the statement is true or false



Joy Chen

  • Sr. Member
  • ****
  • Posts: 354
Answer to Question 1

D

Answer to Question 2

TRUE



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Certain chemicals, after ingestion, can be converted by the body into cyanide. Most of these chemicals have been removed from the market, but some old nail polish remover, solvents, and plastics manufacturing solutions can contain these substances.

Did you know?

Cancer has been around as long as humankind, but only in the second half of the twentieth century did the number of cancer cases explode.

Did you know?

When Gabriel Fahrenheit invented the first mercury thermometer, he called "zero degrees" the lowest temperature he was able to attain with a mixture of ice and salt. For the upper point of his scale, he used 96°, which he measured as normal human body temperature (we know it to be 98.6° today because of more accurate thermometers).

Did you know?

Immunoglobulin injections may give short-term protection against, or reduce severity of certain diseases. They help people who have an inherited problem making their own antibodies, or those who are having certain types of cancer treatments.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library